MJ Fox Foundation gala raises US$5 million for Parkinson’s disease research

News

Author: Parkinson's Life editorsPublished: 17 November 2015

Prep: Cook: Serves:

David Letterman, Denis Leary and John Fogerty along with 1,000 supporters of the Michael J Fox Foundation gathered on Saturday (14 November) for the charity’s annual benefit gala held at the Waldorf Astoria in New York.

Raising more than US$5 million for Parkinson’s research, guests of the A Funny Thing Happened on the Way to Cure Parkinson’s gala were treated to a Marty McFly-themed opening number from host Denis Leary and performances from the likes of Lenny Clarke, Jeff Ross and John Fogerty.

Letterman spoke fondly of Michael and his bravery as a Parkinson’s advocate: “To go out in front of a crowd of strangers without Parkinson’s disease takes gut. You do it with that diagnosis, that’s courage beyond human limits.”

To date, the gala has raised more than US$65 million to fund Parkinson’s disease research.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

One of Facebook’s largest independent Parkinson’s groups

Parkinson’s podcast: ‘New Neurons for Old’ – interview with Dr Roger Barker

The controversial history of foetal tissue and stem cell therapies

Caring and sharing – the importance of learning to let it out

Why good communication is essential in families affected by Parkinson's

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

MJ Fox Foundation gala raises US$5 million for Parkinson’s disease research

News

Author: Parkinson's Life editorsPublished: 17 November 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

Resources & Tools

Parkinson’s podcast: ‘New Neurons for Old’ – interview with Dr Roger Barker

Health & Fitness

Caring and sharing – the importance of learning to let it out

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

MJ Fox Foundation gala raises US$5 million for Parkinson’s disease research

News

Author: Parkinson's Life editorsPublished: 17 November 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Meet Andy Butler, the man behind the Parkinson’s People Facebook group

Resources & Tools

Parkinson’s podcast: ‘New Neurons for Old’ – interview with Dr Roger Barker

Health & Fitness

Caring and sharing – the importance of learning to let it out

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in